Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series

Authors: Chia-Ter Chao, Szu-Ying Lee, Wei-Shun Yang, Huei-Wen Chen, Cheng-Chung Fang, Chung-Jen Yen, Chih-Kang Chiang, Kuan-Yu Hung, Jenq-Wen Huang

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Bacterial infections account for most peritoneal dialysis (PD)-associated peritonitis episodes. However, anaerobic PD peritonitis is extremely rare and intuitively associated with intra-abdominal lesions. In this study, we examined the clinical characteristics of PD patients who developed anaerobic peritonitis.

Methods

We retrospectively identified all anaerobic PD peritonitis episodes from a prospectively collected PD registry at a single center between 1990 and 2010. Only patients receiving more than 3 months of PD were enrolled. We analyzed clinical features as well as outcomes of anaerobic PD peritonitis patients.

Results

Among 6 patients, 10 episodes of PD-associated peritonitis were caused by anaerobic pathogens (1.59% of all peritonitis episodes during study the period), in which the cultures from 5 episodes had mixed growth. Bacteroides fragilis was the most common species identified (4 isolates). Only 3 episodes were associated with gastrointestinal lesions, and 4 episodes were related to a break in sterility during exchange procedures. All anaerobic pathogens were susceptible to clindamycin and metronidazole, but penicillin resistance was noted in 4 isolates. Ampicillin/sulbactam resistance was found in 2 isolates. In 5 episodes, a primary response was achieved using the first-generation cephalosporin and ceftazidime or aminoglycoside. In 3 episodes, the first-generation cephalosporin was replaced with aminoglycosides. Tenckhoff catheter removal was necessary in 2 episodes. Only one episode ended with mortality (due to a perforated bowel).

Conclusion

Anaerobic PD-associated peritonitis might be predominantly caused by contamination, rather than intra-abdominal events. Half of anaerobic PD-associated peritonitis episodes had polymicrobial growth. The overall outcome of anaerobic peritonitis is fair, with a high catheter survival rate.
Literature
1.
go back to reference Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, McDonald SP: Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011, 31: 651-662. 10.3747/pdi.2010.00131.CrossRefPubMed Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, McDonald SP: Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011, 31: 651-662. 10.3747/pdi.2010.00131.CrossRefPubMed
2.
go back to reference Mujais S: Microbiology and outcomes of peritonitis in North America. Kidney Int. 2006, 70: S55-S62.CrossRef Mujais S: Microbiology and outcomes of peritonitis in North America. Kidney Int. 2006, 70: S55-S62.CrossRef
3.
go back to reference Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, Harding G: Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000, 36: 1009-1013. 10.1053/ajkd.2000.19103.CrossRefPubMed Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, Harding G: Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000, 36: 1009-1013. 10.1053/ajkd.2000.19103.CrossRefPubMed
4.
go back to reference Szeto C-C, Kwan BC-H, Chow K-M, Lau M-F, Law M-C, Chung K-Y, Leung C-B, Li P-K: Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol. 2008, 3: 91-97. 10.2215/CJN.03070707.CrossRefPubMedPubMedCentral Szeto C-C, Kwan BC-H, Chow K-M, Lau M-F, Law M-C, Chung K-Y, Leung C-B, Li P-K: Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol. 2008, 3: 91-97. 10.2215/CJN.03070707.CrossRefPubMedPubMedCentral
5.
go back to reference Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections: Chapter 2-5-4. Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary infections, etc.). J Infect Chemother. 2011, 17: 84-91.CrossRef Japanese Society of Chemotherapy Committee on guidelines for treatment of anaerobic infections: Chapter 2-5-4. Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary infections, etc.). J Infect Chemother. 2011, 17: 84-91.CrossRef
6.
go back to reference Hayashi H, Sakamoto M, Benno Y: Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobis culture-based methods. Microbiol Immunol. 2002, 46: 535-548.CrossRefPubMed Hayashi H, Sakamoto M, Benno Y: Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobis culture-based methods. Microbiol Immunol. 2002, 46: 535-548.CrossRefPubMed
7.
go back to reference Chonchol M: Hematology: issues in the dialysis patient: neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial. 2006, 19: 291-296. 10.1111/j.1525-139X.2006.00175.x.CrossRefPubMed Chonchol M: Hematology: issues in the dialysis patient: neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial. 2006, 19: 291-296. 10.1111/j.1525-139X.2006.00175.x.CrossRefPubMed
8.
go back to reference Kambhampati G, Asmar A, Pakkivenkata U, Ather I, Ejaz AA: Anaerobic clavicular osteomyelitis following colonoscopy in a hemodialysis patient. Clin Exp Nephrol. 2011, 15: 780-782. 10.1007/s10157-011-0458-5.CrossRefPubMed Kambhampati G, Asmar A, Pakkivenkata U, Ather I, Ejaz AA: Anaerobic clavicular osteomyelitis following colonoscopy in a hemodialysis patient. Clin Exp Nephrol. 2011, 15: 780-782. 10.1007/s10157-011-0458-5.CrossRefPubMed
9.
go back to reference Ho TT, Labriola L, Jouret F, Yombi JC, Lecouvet F, Jadoul M, Demoulin N: Clostridium perfringens hip arthritis in a hemodialysis patient. Acta Clin Belg. 2012, 67: 49-50.PubMed Ho TT, Labriola L, Jouret F, Yombi JC, Lecouvet F, Jadoul M, Demoulin N: Clostridium perfringens hip arthritis in a hemodialysis patient. Acta Clin Belg. 2012, 67: 49-50.PubMed
10.
go back to reference Cigarrán S, Neches C, Lamas JM, García-Trio G, Alonso M, Saavedra J: A case report of a pyogenic liver abscess caused by fusobacterium nucleatum in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis. Ther Apher Dial. 2008, 12: 91-95. 10.1111/j.1744-9987.2007.00548.x.CrossRefPubMed Cigarrán S, Neches C, Lamas JM, García-Trio G, Alonso M, Saavedra J: A case report of a pyogenic liver abscess caused by fusobacterium nucleatum in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis. Ther Apher Dial. 2008, 12: 91-95. 10.1111/j.1744-9987.2007.00548.x.CrossRefPubMed
11.
go back to reference Li PK-T, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuiiper EJ, Lye WC, Salzer W, Schafer F, Struijk DG, Internation Society for Peritoneal Dialysis: Peritoneal dialysis related infections recommendations: 2010 update. Perit Dial Int. 2010, 30: 393-423. 10.3747/pdi.2010.00049.CrossRefPubMed Li PK-T, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuiiper EJ, Lye WC, Salzer W, Schafer F, Struijk DG, Internation Society for Peritoneal Dialysis: Peritoneal dialysis related infections recommendations: 2010 update. Perit Dial Int. 2010, 30: 393-423. 10.3747/pdi.2010.00049.CrossRefPubMed
12.
go back to reference Piraino B, Bailie G, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuiiper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L, ISPD Ad Hoc Advisory Committee: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005, 25: 107-131.PubMed Piraino B, Bailie G, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuiiper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L, ISPD Ad Hoc Advisory Committee: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005, 25: 107-131.PubMed
13.
go back to reference Keane W, Bailie G, Boeschoten E, Gokal R, Golper T, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S, International Society for Peritoneal Dialysis: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000, 20: 396-411.PubMed Keane W, Bailie G, Boeschoten E, Gokal R, Golper T, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S, International Society for Peritoneal Dialysis: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000, 20: 396-411.PubMed
14.
go back to reference Kofteridis DP, Valachis A, Perakis K, Maraki S, Daphnis E, Samonis G: Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome. Int J Infect Dis. 2010, 14: e489-e493. 10.1016/j.ijid.2009.07.016.CrossRefPubMed Kofteridis DP, Valachis A, Perakis K, Maraki S, Daphnis E, Samonis G: Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome. Int J Infect Dis. 2010, 14: e489-e493. 10.1016/j.ijid.2009.07.016.CrossRefPubMed
15.
go back to reference Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int. 2009, 29: 297-302.PubMed Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int. 2009, 29: 297-302.PubMed
16.
go back to reference Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Moller K, von Baum H, Warady BA: Worldwide variation of dialysis-associated peritonitis in children. Kidney Int. 2007, 72: 1374-1379. 10.1038/sj.ki.5002523.CrossRefPubMed Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Moller K, von Baum H, Warady BA: Worldwide variation of dialysis-associated peritonitis in children. Kidney Int. 2007, 72: 1374-1379. 10.1038/sj.ki.5002523.CrossRefPubMed
17.
go back to reference Suzuki Y, Mizuno M, Nakashima R, Hiramatsu H, Toda S, Sato W, Tsuboi N, Ito I, Maruyama S, Imai E, Matsuo S, Ito Y: A case of perforative peritonitis caused by a piece of bamboo in a patient on peritoneal dialysis. Clin Exp Nephrol. 2011, 15: 962-965. 10.1007/s10157-011-0529-7.CrossRefPubMed Suzuki Y, Mizuno M, Nakashima R, Hiramatsu H, Toda S, Sato W, Tsuboi N, Ito I, Maruyama S, Imai E, Matsuo S, Ito Y: A case of perforative peritonitis caused by a piece of bamboo in a patient on peritoneal dialysis. Clin Exp Nephrol. 2011, 15: 962-965. 10.1007/s10157-011-0529-7.CrossRefPubMed
18.
go back to reference Tzamaloukas A, Obermiller L, Gibel L, Murata G, Wood B, Simon D, Erickson DG, Kanig SP: Peritonitis associated with intra-abdominal pathology in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1993, 13: S335-S337.PubMed Tzamaloukas A, Obermiller L, Gibel L, Murata G, Wood B, Simon D, Erickson DG, Kanig SP: Peritonitis associated with intra-abdominal pathology in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1993, 13: S335-S337.PubMed
19.
go back to reference Ngo JT, Parkins MD, Gregson DB, Pitout JDD, Ross T, Church DL, Laupland KB: Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection. 2013, 41: 41-48. 10.1007/s15010-012-0389-4.CrossRefPubMed Ngo JT, Parkins MD, Gregson DB, Pitout JDD, Ross T, Church DL, Laupland KB: Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection. 2013, 41: 41-48. 10.1007/s15010-012-0389-4.CrossRefPubMed
20.
go back to reference Wilson SE, Hopkins JA: Clinical correlates of anaerobic bacteriology in peritonitis. Clin Infect Dis. 1995, 20: S251-S256. 10.1093/clinids/20.Supplement_2.S251.CrossRefPubMed Wilson SE, Hopkins JA: Clinical correlates of anaerobic bacteriology in peritonitis. Clin Infect Dis. 1995, 20: S251-S256. 10.1093/clinids/20.Supplement_2.S251.CrossRefPubMed
21.
go back to reference Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y: A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. 2006, 12: 527-532. 10.1111/j.1469-0691.2006.01407.x.CrossRefPubMed Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y: A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. 2006, 12: 527-532. 10.1111/j.1469-0691.2006.01407.x.CrossRefPubMed
22.
go back to reference Boyanova L, Mitev A, Gergova G, Mateev G, Mitov I: High prevalence and resistance rates to antibiotics in anaerobic bacteria in specimens from patients with chronic balanitis. Anaerobe. 2012, 18: 414-416. 10.1016/j.anaerobe.2012.06.002.CrossRefPubMed Boyanova L, Mitev A, Gergova G, Mateev G, Mitov I: High prevalence and resistance rates to antibiotics in anaerobic bacteria in specimens from patients with chronic balanitis. Anaerobe. 2012, 18: 414-416. 10.1016/j.anaerobe.2012.06.002.CrossRefPubMed
23.
go back to reference Giamarellou H: Anaerobic infection therapy. Int J Antimicrob Agent. 2000, 16: 341-346. 10.1016/S0924-8579(00)00269-7.CrossRef Giamarellou H: Anaerobic infection therapy. Int J Antimicrob Agent. 2000, 16: 341-346. 10.1016/S0924-8579(00)00269-7.CrossRef
24.
go back to reference Sarap MD, Scher KS, Jones CW: Anaerobic coverage for wound prophylaxis: comparison of cefazolin and cefoxitin. Am J Surg. 1986, 151: 213-215. 10.1016/0002-9610(86)90072-3.CrossRefPubMed Sarap MD, Scher KS, Jones CW: Anaerobic coverage for wound prophylaxis: comparison of cefazolin and cefoxitin. Am J Surg. 1986, 151: 213-215. 10.1016/0002-9610(86)90072-3.CrossRefPubMed
25.
go back to reference Maki DG, Aughey DR: Comparative study of cefazolin, cefoxitin, and ceftizoxime for surgical prophylaxis in colo-rectal surgery. J Antimicrob Chemother. 1982, 10: 281-287. 10.1093/jac/10.suppl_C.281.CrossRefPubMed Maki DG, Aughey DR: Comparative study of cefazolin, cefoxitin, and ceftizoxime for surgical prophylaxis in colo-rectal surgery. J Antimicrob Chemother. 1982, 10: 281-287. 10.1093/jac/10.suppl_C.281.CrossRefPubMed
26.
go back to reference Yap DY, To KK, Yip TP, Lui SL, Chan TM, Lai KN, Lo WK: Streptococcus bovis peritonitis complicating peritoneal dialysis—a review of 10 years’ experience. Perit Dial Int. 2012, 32: 55-59. 10.3747/pdi.2010.00304.CrossRefPubMedPubMedCentral Yap DY, To KK, Yip TP, Lui SL, Chan TM, Lai KN, Lo WK: Streptococcus bovis peritonitis complicating peritoneal dialysis—a review of 10 years’ experience. Perit Dial Int. 2012, 32: 55-59. 10.3747/pdi.2010.00304.CrossRefPubMedPubMedCentral
Metadata
Title
Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series
Authors
Chia-Ter Chao
Szu-Ying Lee
Wei-Shun Yang
Huei-Wen Chen
Cheng-Chung Fang
Chung-Jen Yen
Chih-Kang Chiang
Kuan-Yu Hung
Jenq-Wen Huang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-111

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.